APTO Projected Dividend Yield
Com No Par/Aptose Biosciences Inc ( NASDAQ : APTO )Aptose Biosciences Inc. is a clinical-stage biotechnology company engaged in developing precision medicines addressing unmet medical needs in oncology, with an initial focus on hematology. Co.'s small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities. 20 YEAR PERFORMANCE RESULTS |
APTO Dividend History Detail APTO Dividend News APTO Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |